利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

37 条记录 (耗时 0.055 秒)

    Interpolation method for captured color image data
    1.
    发明授权
    Interpolation method for captured color image data 失效
    捕获彩色图像数据的插值方法

    公开(公告)号：US07652700B2

    公开(公告)日：2010-01-26

    申请号：US11661709

    申请日：2005-07-27

    申请人： Yoshihisa Takahashi ,  Hisakazu Kikuchi ,  Shogo Muramatsu ,  Yoshito Abe ,  Naoki Mizutani

    发明人： Yoshihisa Takahashi ,  Hisakazu Kikuchi ,  Shogo Muramatsu ,  Yoshito Abe ,  Naoki Mizutani

    IPC分类号： H04N3/14 ,  H04N5/335 ,  H04N9/04 ,  H04N9/083 ,  H04N5/228

    CPC分类号： G06T3/4015 ,  H04N1/648 ,  H04N9/045

    摘要： To achieve more appropriate interpolation of a missing pixel, an image is input to a processing section for interpolation. The interpolation is applied utilizing image data of pixels located around the pixel to be interpolated. Specifically, correlations between the image data of the pixels to be interpolated, and pixel data in a horizontal direction, vertical direction, and diagonal direction, are compared to one another; pixel data having stronger correlation is used for the interpolation. Correlation between the image data of the pixels to be interpolated and which direction is strong is determined, so that different weighting for interpolation is used accordingly.

    摘要翻译： 为了实现对缺失像素的更合适的插值，将图像输入到用于插值的处理部分。 使用位于要内插的像素周围的像素的图像数据来应用插值。 具体而言，将要内插的像素的图像数据与水平方向，垂直方向和对角线方向上的像素数据之间的相关性相互比较; 使用具有较强相关性的像素数据进行插值。 确定要插值的像素的图像数据和哪个方向是强的相关性，使得相应地使用用于插值的不同加权。

    Interpolation Method for Captured Color Image Data
    2.
    发明申请
    Interpolation Method for Captured Color Image Data 失效
    捕获的彩色图像数据的插值方法

    公开(公告)号：US20070247530A1

    公开(公告)日：2007-10-25

    申请号：US11661709

    申请日：2005-07-29

    申请人： Yoshihisa Takahasi ,  Hisakazu Kikuchi ,  Shogo Muramatsu ,  Yoshito Abe ,  Naoki Mizutani

    发明人： Yoshihisa Takahasi ,  Hisakazu Kikuchi ,  Shogo Muramatsu ,  Yoshito Abe ,  Naoki Mizutani

    IPC分类号： H04N9/73 ,  G06T3/40 ,  H04N9/04

    CPC分类号： G06T3/4015 ,  H04N1/648 ,  H04N9/045

    摘要： To achieve more appropriate interpolation of a missing pixel, an image is input to a processing section for interpolation. The interpolation is applied utilizing image data of pixels located around the pixel to be interpolated. Specifically, correlations between the image data of the pixels to be interpolated, and pixel data in a horizontal direction, vertical direction, and diagonal direction, are compared to one another; pixel data having stronger correlation is used for the interpolation. Correlation between the image data of the pixels to be interpolated and which direction is strong is determined, so that different weighting for interpolation is used accordingly.

    摘要翻译： 为了实现对缺失像素的更合适的插值，将图像输入到用于插值的处理部分。 使用位于要内插的像素周围的像素的图像数据来应用插值。 具体而言，将要内插的像素的图像数据与水平方向，垂直方向和对角线方向上的像素数据之间的相关性相互比较; 使用具有较强相关性的像素数据进行插值。 确定要插值的像素的图像数据和哪个方向是强的相关性，使得相应地使用用于插值的不同加权。

    Aromatic ring derivatives
    4.
    发明授权
    Aromatic ring derivatives 失效
    芳香环衍生物

    公开(公告)号：US06242474B1

    公开(公告)日：2001-06-05

    申请号：US09446619

    申请日：2000-03-21

    申请人： Noritsugu Yamasaki ,  Takafumi Imoto ,  Takahiro Hiramura ,  Osamu Onomura ,  Masahiro Nishikawa ,  Hiroshi Kayakiri ,  Yoshito Abe ,  Hitoshi Hamashima ,  Hitoshi Sawada

    发明人： Noritsugu Yamasaki ,  Takafumi Imoto ,  Takahiro Hiramura ,  Osamu Onomura ,  Masahiro Nishikawa ,  Hiroshi Kayakiri ,  Yoshito Abe ,  Hitoshi Hamashima ,  Hitoshi Sawada

    IPC分类号： A61K314164

    CPC分类号： C07D213/78 ,  C07C311/51 ,  C07D213/81 ,  C07D233/64 ,  C07D233/68 ,  C07D409/06

    摘要： Novel aromatic ring derivatives represented by formula (I) or their pharmaceutical acceptable salts are provided. wherein Nu represents a 5- or 6-membered aromatic ring; ch1 and ch2 each represents a cross-linking group; and A represents an aromatic ring. These compounds have blood sugar-depressing activity or PDE 5 inhibitory activity and are useful as medicines for treating impaired glucose tolerance, diabetes, diabetic complications, syndrome of insulin-resistance, polycystic ovary syndrome, hyperlipidemia, atherosclerosis, cardiovascular disorders, hyperglycemia, hypertension, stenocardia, pulmonary hypertension, congestive heart failure, glomerulopathy, tubulointerstitial disorders, renal failure, angiostenosis, distal angiopathy, cerebral apoplexy, chronic reversible obstructions, autoimmune diseases, allergic rhinitis, urticaria, glaucoma, diseases characterized by enteromotility disorders, impotence, nephritis, cachexia, pancreatitis, restenosis after PTCA, etc.

    摘要翻译： 提供由式（I）表示的新颖芳环衍生物或其药学上可接受的盐。其中Nu表示5-或6-元芳环; ch1和ch2各自表示交联基团; 并且A代表芳香环。这些化合物具有抑制血糖的活性或PDE 5抑制活性，可用作治疗糖耐量异常，糖尿病，糖尿病并发症，胰岛素抵抗综合征，多囊卵巢综合症，高脂血症，动脉粥样硬化， 心血管疾病，高血糖症，高血压，心律失常，肺动脉高压，充血性心力衰竭，肾小球病，肾小管间质性疾病，肾衰竭，血管狭窄，远端血管病，脑中风，慢性可逆障碍，自身免疫性疾病，过敏性鼻炎，荨麻疹，青光眼，以肠蠕动为特征的疾病 疾病，阳ence，肾炎，恶病质，胰腺炎，PTCA后再狭窄等。

    Method of preparing certain 3-halo-imidazopyridines
    6.
    发明授权
    Method of preparing certain 3-halo-imidazopyridines 失效
    制备某些3-卤代 - 咪唑并吡啶的方法

    公开(公告)号：US5750699A

    公开(公告)日：1998-05-12

    申请号：US662198

    申请日：1996-06-12

    申请人： Teruo Oku ,  Hiroshi Kayakiri ,  Shigeki Satoh ,  Yoshito Abe ,  Yuki Sawada ,  Hirokazu Tanaka

    发明人： Teruo Oku ,  Hiroshi Kayakiri ,  Shigeki Satoh ,  Yoshito Abe ,  Yuki Sawada ,  Hirokazu Tanaka

    IPC分类号： C07D471/04 ,  C07D471/02

    CPC分类号： C07D471/04

    摘要： The invention relates to bradykinin antagonists of the formula: ##STR1## wherein R.sup.1 is halogen, R.sup.2 and R.sup.3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl, R.sup.4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s), Q is O or N--R.sup.11, in which R.sup.11 is hydrogen or acyl, and A is lower alkylene, and pharmaceutically acceptable salts thereof.

    摘要翻译： 本发明涉及下式的缓激肽拮抗剂：其中R 1为卤素，R 2和R 3各自为氢，低级烷基，卤代（低级）烷基或酰基，R 4为具有合适取代基的芳基或杂环基 任选具有合适的取代基，Q是O或N-R 11，其中R 11是氢或酰基，A是低级亚烷基，及其药学上可接受的盐。

    Image synthesizing apparatus and image pickup apparatus with a brightness adjusting processing
    8.
    发明授权
    Image synthesizing apparatus and image pickup apparatus with a brightness adjusting processing 有权
    具有亮度调整处理的图像合成装置和图像拾取装置

    公开(公告)号：US08026962B2

    公开(公告)日：2011-09-27

    申请号：US12397726

    申请日：2009-03-04

    申请人： Yoshito Abe ,  Kazunori Kita

    发明人： Yoshito Abe ,  Kazunori Kita

    IPC分类号： H04N5/217

    CPC分类号： H04N5/243 ,  G06T5/002 ,  G06T5/009 ,  G06T5/40 ,  G06T5/50 ,  G06T2207/10016 ,  G06T2207/20221

    摘要： Disclosed is an image synthesizer including an image frames memory which memorizes a plurality of image frames which are produced by continuously taking pictures of a subject, an image synthesizer which synthesizes a plurality of image frames to a summation image, an image brightness adjuster which adjusts brightness of the summation image by synthesizing the image frames with the image synthesizer, and a display which displays the summation image which is being synthesized by the image synthesizing means in the image brightness adjusting processing.

    摘要翻译： 公开了一种图像合成器，包括存储多个图像帧的图像帧存储器，所述图像帧存储器通过连续拍摄被摄体的图像，合成多个图像帧的图像合成器到和图像，调整亮度的图像亮度调节器 通过与图像合成器合成图像帧，以及在图像亮度调整处理中显示由图像合成装置合成的求和图像的显示。

    HETERO COMPOUND
    9.
    发明申请
    HETERO COMPOUND 有权
    HETERO化合物

    公开(公告)号：US20100168159A1

    公开(公告)日：2010-07-01

    申请号：US12696327

    申请日：2010-01-29

    申请人： Hironori Harada ,  Kazuyuki Hattori ,  Kazuya Fujita ,  Masataka Morita ,  Sunao Imada ,  Yoshito Abe ,  Hiromichi Itani ,  Tatsuaki Morokata ,  Hideo Tsutsumi

    发明人： Hironori Harada ,  Kazuyuki Hattori ,  Kazuya Fujita ,  Masataka Morita ,  Sunao Imada ,  Yoshito Abe ,  Hiromichi Itani ,  Tatsuaki Morokata ,  Hideo Tsutsumi

    IPC分类号： A61K31/4439 ,  A61K31/4709 ,  C07D471/04 ,  C07D413/14 ,  A61P35/02 ,  A61P37/06 ,  A61P29/00 ,  A61P9/10 ,  A61P35/00

    CPC分类号： C07D413/04 ,  C07D417/04 ,  C07D471/04

    摘要： [Problems]To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 agonist activity.[Means for solving]Since the compound of the invention has an S1P1 agonist activity, it is useful as an active ingredient for a treating or preventing agent for a disease caused by unfavorable lymphocytic infiltration, for example, an autoimmune disease such as graft rejection in the transplantation of an organ, bone marrow, or a tissue, a graft-versus-host disease, rheumatic arthritis, multiple sclerosis, systemic lupus erythematosus, a nephrotic syndrome, encephalomeningitis, myasthenia gravis, pancreatitis, hepatitis, nephritis, diabetes, pulmonary disorder, asthma, atopic dermatitis, inflammatory bowel disease, atherosclerosis, ischemia-reperfusion injury, or an inflammatory disease, and further, a disease caused by the abnormal growth or accumulation of cells such as cancer and leukemia.

    摘要翻译： [问题]提供一种有用的化合物作为活性成分，用于预防和/或治疗移植器官，骨髓或组织，自身免疫疾病等中的排斥反应，其具有优异的S1P1激动剂 活动。 [解决方法]由于本发明的化合物具有S1P1激动剂活性，因此可用作由不利的淋巴细胞浸润引起的疾病的治疗或预防剂的活性成分，例如自身免疫性疾病如移植排斥反应 器官移植，骨髓或组织，移植物抗宿主病，风湿性关节炎，多发性硬化，系统性红斑狼疮，肾病综合征，脑炎，重症肌无力，胰腺炎，肝炎，肾炎，糖尿病，肺功能障碍 哮喘，特应性皮炎，炎症性肠病，动脉粥样硬化，局部缺血再灌注损伤，炎症性疾病等疾病，以及癌症，白血病等细胞异常生长或积累引起的疾病。